Operating Lease, Right-of-Use Asset of Sana Biotechnology, Inc. from 31 Dec 2020 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Sana Biotechnology, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2020 to 31 Dec 2025.
  • Sana Biotechnology, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $38,313,000, a 34% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Sana Biotechnology, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $38,313,000 -$19,648,000 -34% 31 Dec 2025 10-K 03 Mar 2026 2025 FY
Q3 2025 $40,704,000 -$20,336,000 -33% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $43,021,000 -$20,133,000 -32% 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 $54,837,000 -$16,728,000 -23% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $57,961,000 -$16,942,000 -23% 31 Dec 2024 10-K 03 Mar 2026 2025 FY
Q3 2024 $61,040,000 -$16,195,000 -21% 30 Sep 2024 10-Q 08 Nov 2024 2024 Q3
Q2 2024 $63,154,000 -$31,561,000 -33% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $71,565,000 -$26,551,000 -27% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 $74,903,000 -$17,583,000 -19% 31 Dec 2023 10-K 17 Mar 2025 2024 FY
Q3 2023 $77,235,000 -$18,498,000 -19% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 $94,715,000 -$4,195,000 -4.2% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 $98,116,000 +$971,000 +1% 31 Mar 2023 10-Q 08 May 2023 2023 Q1
Q4 2022 $92,486,000 -$3,834,000 -4% 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q3 2022 $95,733,000 +$10,905,000 +13% 30 Sep 2022 10-Q 02 Nov 2022 2022 Q3
Q2 2022 $98,910,000 +$38,580,000 +64% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 $97,145,000 +$35,375,000 +57% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 $96,320,000 +$33,152,000 +52% 31 Dec 2021 10-K 16 Mar 2023 2022 FY
Q3 2021 $84,828,000 30 Sep 2021 10-Q 08 Nov 2021 2021 Q3
Q2 2021 $60,330,000 30 Jun 2021 10-Q 04 Aug 2021 2021 Q2
Q1 2021 $61,770,000 31 Mar 2021 10-Q 05 May 2021 2021 Q1
Q4 2020 $63,168,000 31 Dec 2020 10-K 16 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.